GRPR and gastrointestinal stromal tumor: BMI also showed a positive correlation with lesions SUVmax, while all other assessed parameters—age, disease duration, progressive disease state, first-line treatment, lesion localization, and lesions volume—exhibited no decisive correlation with tracer uptake, in part mirroring previous study results demonstrating stable GRPR expression in GIST cells regardless of disease stage or treatment [15].